Antimicrobial Stewardship Dashboard

The Antimicrobial Stewardship Dashboard consolidates therapy orders, microbiology results, and outcome data into a unified, SMART on FHIR–enabled view. It provides infectious disease (ID) and pharmacy teams with actionable insight into antimicrobial use, emerging resistance trends, and adherence to local and national stewardship guidelines.

By integrating prescribing data with culture and sensitivity results, this dashboard helps clinicians identify opportunities for de-escalation, therapy narrowing, or early discontinuation, reducing both clinical risk and cost while strengthening stewardship program accountability.

Benefits

• Improved antimicrobial use: Enables targeted therapy, de-escalation, and timely discontinuation to align with stewardship goals.
• Resistance reduction and containment: Visualizes susceptibility trends and resistance patterns across units and facilities.
• Operational efficiency: Equips stewardship and ID teams with consolidated data for daily rounds and reporting.
• Policy compliance and transparency: Tracks adherence to stewardship guidelines and supports audit and accreditation reviews.

Capabilities

• SMART on FHIR panel with drill-down: Provides dynamic, EMR-embedded access to antimicrobial use and resistance data at patient, unit, or facility levels.
• Antibiogram integration: Displays unit- and facility-specific susceptibility profiles sourced from microbiology systems via HL7v2 or FHIR interfaces.
• Utilization and DOT metrics: Tracks days of therapy (DOT), defined daily doses (DDD), and other utilization metrics over time.
• Guideline adherence monitoring: Surfaces compliance with institutional and national stewardship recommendations (e.g., IDSA, CDC).
• Stewardship alerts and reports: Generates targeted notifications for prolonged therapy, broad-spectrum use, or missed de-escalation opportunities.

Great for

• Clinical Informatics and EMR Analysts: Integrate antimicrobial utilization and microbiology data into SMART on FHIR dashboards for stewardship and governance insight.
• Infectious Disease and Stewardship Teams: Drive real-time therapy optimization and guideline adherence through visibility into culture, therapy, and outcome data.
• Pharmacy and Quality Improvement Leads: Monitor antimicrobial metrics and resistance trends to guide formulary management and policy alignment.
• Compliance and Accreditation Officers: Demonstrate defensible stewardship program outcomes using standardized metrics and audit-ready documentation.